WallStreetZenWallStreetZen

How to Buy Lyell Immunopharma Stock

Lyell Immunopharma Inc

Lyell Immunopharma, Inc. , a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors.

Lyell Immunopharma stock last closed at $2.33, down 2.1% from the previous day, and has decreased 2.1% in one year. It has overperformed other stocks in the Biotechnology industry by 0.24 percentage points. Lyell Immunopharma stock is currently +76.52% from its 52-week low of $1.32, and -41.31% from its 52-week high of $3.97.

At the moment, there are 254.1M LYEL shares outstanding. The market cap of LYEL is $592.04M. In the past 24 hours, 906,617 LYEL shares were traded.

How to Buy Lyell Immunopharma Stock

Wondering how to invest in Lyell Immunopharma stock? Here's how.
  1. Figure out where to buy Lyell Immunopharma stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you choose where to buy Lyell Immunopharma stock.
  2. Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your investment account: Choose your method of payment and add your details.
  4. Analyze Lyell Immunopharma stock: The Lyell Immunopharma ticker symbol is LYEL. Is Lyell Immunopharma stock a good investment? Should you buy shares of LYEL? How do LYEL's underlying business fundamentals look? Do top analysts think Lyell Immunopharma is a good buy? Why has LYEL's stock price moved recently? (Hint: Our stock research website can help you decide if LYEL is a good stock to buy).
  5. Place your LYEL buy order: Decide if you will purchase LYEL shares at the current market price or use a limit order to buy LYEL stock at a specific price.
  6. Keep an eye on your investment in LYEL: Create a watchlist to monitor your new investment in Lyell Immunopharma shares.

Step 1: Figure out where to buy Lyell Immunopharma stock

You need a brokerage account in order to access the NASDAQ market and buy LYEL stock.

A brokerage account allows you to buy and sell a variety of investments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

We believe that eToro is the best place to buy stocks. Here's why:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world markets: From Technology to Energy, New York to Tokyo — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of shares by signing up for an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've picked your brokerage, you need to fill out some personal details so you can buy LYEL stock today.

How to Start a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to create a new trading account.
  1. Send your info by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you've created your account on the best free stock trading app, your next step is to transfer the money for your investment:

Watch this video walkthrough to see the process of transferring money into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Lyell Immunopharma stock

Once you have identified the best place to buy Lyell Immunopharma stock, it's absolutely critical to analyze their stock before you buy, so you actually understand the risk as well as the upside.

Lyell Immunopharma Metrics

LYEL Price
$2.33
1w %
-12.41%
1y %
-2.1%
5y %
N/A
P/E
-2.51x
P/B
0.9x
P/S
2,330x
PEG
N/A
Revenue
$130.00k
Earnings
-$234.63M
Fore. Rev. Growth
7,592.31%
Fore. Earn. Growth
N/A
Market Cap
$592.04M
Next Earnings
May 7, 2024
Next Dividend
N/A

LYEL Overview

WallStreetZen was designed to help average investors perform better fundamental analysis quickly.

You can view all of the due diligence checks on LYEL's stock page.

What is the fair value of LYEL stock?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge LYEL's intrinsic value.

Using relative valuations metrics:

  • LYEL may be undervalued based on its P/B ratio of 0.9x, relative to Biotechnology industry P/B ratio of 5.76x

You can do more valuation research on LYEL's stock here.

How do LYEL Financials look?

Positive Financial Indicators:

  • LYEL has $546.51M in cash and short term investments. This is enough to cover its annual cash burn of $166.38M.
  • LYEL has cash burn of 166380000. It has enough cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the LYEL balance sheet.
  • There are more short-term assets than short-term liabilities on the LYEL balance sheet.
  • LYEL has a low debt to equity ratio of 0.15.

Negative Financial Indicators:

  • LYEL profit margin has gone down from -216.2% to -180,486.2% in the past year.

Is Lyell Immunopharma stock a Buy, Hold, or Sell, according to analysts?

Out of 1 Equities analysts who track LYEL, the consensus analyst rating on LYEL is a Buy

Please note that analyst forecasts are not stock recommendations, nor are they investment advice.

You can dig deeper into what analysts are projecting on the Lyell Immunopharma stock forecast page.

LYEL Technicals

SMA10
2.44
SMA20
2.25
SMA50
2.26
SMA100
2.12
SMA200
2.12
MACD
0.07
MACD Signal
0.05
MACD Histogram
0.02
RSI
50.51
Stochastic %K
33.43
Stochastic %D
42.38
StochRSI %K
23.69
StochRSI %D
36.75

LYEL Revenue

Last year, LYEL revenue was $130.00k. Over the last 4 year, LYEL's revenue has grown by -33.3% per year. This was slower than the Biotechnology industry average of 28.98%.

Dive into LYEL's earnings and revenue performance here.

Latest Insiders Trades at LYEL

In the past 12 months, insiders at LYEL have sold more shares than they have bought.

Richard Klausner, Director of LYEL, was the latest LYEL insider to sell. They sold $132,285.60 worth of LYEL shares on Aug 15, 2023.

Learn more about who owns LYEL stock here.

Can I get consistent income from LYEL stock?

No, Lyell Immunopharma doesn't provide an income stream by paying out dividends.

What others are saying about LYEL

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other community members have to say.

Step 5: Place your LYEL buy order

You have two main types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are usually the easiest way to buy.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at an exact dollar amount, use a limit order.

Press the Open button and eToro will execute your order.

If you want additional info about buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Keep an eye on your investment in LYEL

Now that you own some shares in LYEL, you'll want to keep up with your stock purchase.

Create a watchlist to monitor your LYEL stock.

LYEL Feed

How to Buy Stock in Lyell Immunopharma

To summarize, here are the 6 steps to buy stock in Lyell Immunopharma:

  1. Figure out where to buy Lyell Immunopharma stock
  2. Sign up for a brokerage account
  3. Deposit funds into your investment account
  4. Analyze Lyell Immunopharma stock
  5. Place your LYEL buy order
  6. Keep an eye on your investment in LYEL

If you are looking for a online brokerage, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get the latest scoop on your new investment in Lyell Immunopharma, add LYEL to your watchlist by clicking the button below.

NASDAQ: LYEL
$2.33-0.05 (-2.1%)
Updated Apr 18, 2024
Open eToro Account
NASDAQ: LYEL
$2.33-0.05 (-2.1%)
Updated Apr 18, 2024
Open eToro Account

FAQ

How much does it cost to buy one Lyell Immunopharma share?

As of Apr 18, 2024, it costs $2.33 to buy one share of Lyell Immunopharma stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.429 shares of LYEL.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Lyell Immunopharma stock?

According to 1 Wall Street analysts who monitor Lyell Immunopharma, their consensus recommendation is to buy Lyell Immunopharma stock.

What is the best way to buy Lyell Immunopharma stock?

One way to place an order for Lyell Immunopharma stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.